AS
Anandkumar Shankardayal Tiwari
About Anandkumar Shankardayal Tiwari
Data last updated:
Anandkumar Shankardayal Tiwari has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Alican Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alican Pharmaceutical Private Limited at ₹2.57 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2022 | 2021 | ₹2.57 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anandkumar Shankardayal Tiwari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anandkumar Shankardayal Tiwari
Anandkumar Shankardayal Tiwari has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Alican Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alican Pharmaceutical Private Limited at ₹2.57 Cr (FY 2025).
Anandkumar Shankardayal Tiwari is associated with 1 company as Director, including Alican Pharmaceutical Private Limited (₹2.57 Cr).
Anandkumar Shankardayal Tiwari has expertise in General Business.
Anandkumar Shankardayal Tiwari has 4 years in corporate governance.
By reported revenue, the largest current company of Anandkumar Shankardayal Tiwari is Alican Pharmaceutical Private Limited, with revenue of ₹2.57 Cr (FY 2025).
Anandkumar Shankardayal Tiwari currently holds positions at 1 company: Alican Pharmaceutical Private Limited (₹2.57 Cr).